The controversy over the efficacy of pneumococcal vaccine

Andrews, Ross; Moberley, Sarah A.
January 2009
CMAJ: Canadian Medical Association Journal;1/6/2009, Vol. 180 Issue 1, p18
Academic Journal
The author reflects on the meta-analysis of Huss and colleagues regarding the efficacy of pneumococcal polysaccharide vaccine in adults. The author compares the present study with the Cochrane review by citing the excluded several related studies. The author argues that the exclusion of lung tissue infection is inappropriate for the diagnosis of pneumonia. The author also contends that the conclusion of the study regarding the benefit of childhood immunization is beyond the scope of the study.


Related Articles

  • Efficacy of pneumococcal vaccination in adults: a meta-analysis. Huss, Anke; Scott, Pippa; Stuck, Andreas E.; Trotter, Caroline; Egger, Matthias // CMAJ: Canadian Medical Association Journal;1/6/2009, Vol. 180 Issue 1, p48 

    Background: Clinical trials and meta-analyses have produced conflicting results of the efficacy of unconjugated pneumococcal polysaccharide vaccine in adults. We sought to evaluate the vaccine's efficacy on clinical outcomes as well as the methodologic quality of the trials. Methods: We searched...

  • Immune Response to Pneumococcal Conjugate and Polysaccharide Vaccines in Otitis-Prone and Otitis-Free Children. Barnett, Elizabeth D.; Pelton, Stephen I.; Cabral, Howard J.; Eavey, Roland D.; Allen, Carole; Cunningham, Michael J.; McNamara, Eileen R.; Klein, Jerome O. // Clinical Infectious Diseases;7/1/99, Vol. 29 Issue 1, p191 

    Provides information on a study which compared responses to the pneumococcal conjugate vaccine (PCV) and pneumococcal polysaccharide vaccine to understand the roles of vaccines in the prevention of pneumococcal disease including otitis media. How the study was conducted; Results; Discussion of...

  • Protecting against invasive pneumococcal disease: Be wise--immunize! Squires, Susan G.; Spika, John S. // CMAJ: Canadian Medical Association Journal;10/06/98, Vol. 159 Issue 7, p826 

    Discusses invasive pneumococcal pneumonia. Characteristics; Treatment choices; Recommendations from the Canadian Immunization Guide; Introduction of pneumococcal vaccination programs for high-risk groups in Canada.

  • The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis. Rozenbaum, M.; Pechlivanoglou, P.; Werf, T.; Lo-Ten-Foe, J.; Postma, M.; Hak, E. // European Journal of Clinical Microbiology & Infectious Diseases;Mar2013, Vol. 32 Issue 3, p305 

    The primary objective of this meta-analysis was to estimate the prevalence of adult community-acquired pneumonia (CAP) caused by Streptococcus pneumoniae in Europe, adjusted for possible independent covariates. Two reviewers conducted a systematic literature search using PubMed on...

  • Summary of NACI Statement: Interim Recommendations on the Use of Pneumococcal Vaccines in Immunocompetent Adults 65 Years of Age and Older. Quach, C.; Baclic, O. // Canada Communicable Disease Report;Dec2016, Vol. 42 Issue 12, p260 

    Background: Since 2015, pneumococcal 13-valent conjugate vaccine (PNEU-C-13) has been authorized for the prevention of invasive pneumococcal disease (IPD) and pneumococcal community-acquired pneumonia (CAP) in adults. Adults with immunocompromising conditions are still recommended to receive...

  • Initial and Subsequent Response to Pneumococcal Polysaccharide and Protein-Conjugate Vaccines Administered Sequentially to Adults Who Have Recovered from Pneumococcal Pneumonia. Musher, Daniel M.; Rueda, Adriana M.; Nahm, Moon H.; Graviss, Edward A.; Rodriguez-Barradas, Maria C. // Journal of Infectious Diseases;10/1/2008, Vol. 198 Issue 7, p1019 

    Background. Controversy persists over the benefits of pneumococcal polysaccharide vaccine (PPV) for adults at high risk for pneumococcal disease. We studied PPV, protein-conjugate pneumococcal vaccine (PCV), and immunologic "priming" with PCV followed by "boosting" with PPV in adults who had...

  • Pneumonia care in the community. Merriman, Honor // GP: General Practitioner;11/16/2007, p38 

    The article presents information about community-acquired pneumonia, its symptoms, diagnosis, and treatment. Its symptoms include fever, increased respiratory rate, and reduced air entry. Pulse oximeter is suggested for its diagnosis. Patients with severe disease should also be tested for...

  • Appropriateness of a Pneumococcal Conjugate Vaccine in Brazil: Potential Impact of Age and Clinical Diagnosis, with Emphasis on Meningitis. Brandileone, Maria-Cristina C.; Sgambatti de Andrade, Ana-Lucia S.; Di Fabio, José-Luis; Guerra, Maria-Luiza L.S.; Austrian, Robert // Journal of Infectious Diseases;4/15/2003, Vol. 187 Issue 8, p1206 

    Analyzes the distribution of pneumococcal serotypes in Brazil by age group and clinical diagnosis, using data obtained during 20 years of national surveillance. Indication that serotypes 1 and 5 are among the main serotypes in all age groups; Finding that the use of conjugate vaccine may be of...

  • Pneumococcal 7-valent-crm197 vaccine conjugate/pneumococcal vaccine/tosufloxacin.  // Reactions Weekly;Oct2015, Vol. 1573 Issue 1, p181 

    The article presents a case study of an 80-month-old girl with tosufloxacin resistance in streptococcus pneumoniae pneumonia which developed after pneumococcal 7-valent-crm197 vaccine conjugate and pneumococcal vaccine.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics